Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 2
2010 1
2011 1
2012 2
2013 3
2015 3
2020 2
2021 1
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Glycosphingolipid metabolism and polycystic kidney disease.
Natoli TA, Modur V, Ibraghimov-Beskrovnaya O. Natoli TA, et al. Among authors: modur v. Cell Signal. 2020 May;69:109526. doi: 10.1016/j.cellsig.2020.109526. Epub 2020 Jan 10. Cell Signal. 2020. PMID: 31911181 Free article. Review.
Biomarkers in Pharmaceutical Research.
Zhao X, Modur V, Carayannopoulos LN, Laterza OF. Zhao X, et al. Among authors: modur v. Clin Chem. 2015 Nov;61(11):1343-53. doi: 10.1373/clinchem.2014.231712. Epub 2015 Sep 25. Clin Chem. 2015. PMID: 26408531 Review.
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
Gansevoort RT, Hariri A, Minini P, Ahn C, Chapman AB, Horie S, Knebelmann B, Mrug M, Ong ACM, Pei YPC, Torres VE, Modur V, Antonshchuk I, Perrone RD. Gansevoort RT, et al. Among authors: modur v. Am J Kidney Dis. 2023 May;81(5):517-527.e1. doi: 10.1053/j.ajkd.2022.10.016. Epub 2022 Dec 17. Am J Kidney Dis. 2023. PMID: 36535535 Free article. Clinical Trial.
Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension study.
Deegan PB, Goker-Alpan O, Geberhiwot T, Hopkin RJ, Lukina E, Tylki-Szymanska A, Zaher A, Sensinger C, Gaemers SJM, Modur V, Thurberg BL, Sharma J, Najafian B, Mauer M, DasMahapatra P, Wilcox WR, Germain DP. Deegan PB, et al. Among authors: modur v. Mol Genet Metab. 2023 Feb;138(2):106963. doi: 10.1016/j.ymgme.2022.11.002. Epub 2022 Nov 9. Mol Genet Metab. 2023. PMID: 36481125 Free PMC article. Clinical Trial.
Are companion diagnostics useful?
Barrett JC, Frigault MM, Hollingsworth S, Miller GA, Modur V. Barrett JC, et al. Among authors: modur v. Clin Chem. 2013 Jan;59(1):198-201. doi: 10.1373/clinchem.2012.185132. Epub 2012 Nov 28. Clin Chem. 2013. PMID: 23193059 No abstract available.
Correction of cilia structure and function alleviates multi-organ pathology in Bardet-Biedl syndrome mice.
Husson H, Bukanov NO, Moreno S, Smith MM, Richards B, Zhu C, Picariello T, Park H, Wang B, Natoli TA, Smith LA, Zanotti S, Russo RJ, Madden SL, Klinger KW, Modur V, Ibraghimov-Beskrovnaya O. Husson H, et al. Among authors: modur v. Hum Mol Genet. 2020 Aug 29;29(15):2508-2522. doi: 10.1093/hmg/ddaa138. Hum Mol Genet. 2020. PMID: 32620959 Free PMC article.
Identification of novel brain biomarkers.
Laterza OF, Modur VR, Crimmins DL, Olander JV, Landt Y, Lee JM, Ladenson JH. Laterza OF, et al. Among authors: modur vr. Clin Chem. 2006 Sep;52(9):1713-21. doi: 10.1373/clinchem.2006.070912. Epub 2006 Jul 20. Clin Chem. 2006. PMID: 16858073
Biomarkers of tissue injury.
Laterza OF, Modur VR, Ladenson JH. Laterza OF, et al. Among authors: modur vr. Biomark Med. 2008 Feb;2(1):81-92. doi: 10.2217/17520363.2.1.81. Biomark Med. 2008. PMID: 20477365
20 results